Every medicine has risks and benefits
If you need help discussing GLP-1 with others, our guide on what to say when requesting GLP-1 options offers practical conversation templates
Revs up overnight metabolism to burn fat as you rest
Two weeks before starting retatrutide: Begin a daily probiotic
Foods with higher fat content can also remain in the stomach for a longer period, intensifying the feeling of fullness
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively